|
Lymphoid Neoplasia
Citations 81-90 of 299 total displayed.
|
Past content
(since Jan 2009):
|
A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia
- Nina S. Kadan-Lottick, Pim Brouwers, David Breiger, Thomas Kaleita, James Dziura, Haibei Liu, Lu Chen, Megan Nicoletti, Linda Stork, Bruce Bostrom, and Joseph P. Neglia
Blood 2009; 114: 1746-1752.
[Abstract]
[Full text]
[PDF]
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth
- Angela Pennisi, Wen Ling, Xin Li, Sharmin Khan, John D. Shaughnessy, Jr, Bart Barlogie, and Shmuel Yaccoby
Blood 2009; 114: 1803-1812.
[Abstract]
[Full text]
[PDF]
How I treat mantle cell lymphoma
- Michele Ghielmini and Emanuele Zucca
Blood 2009; 114: 1469-1476.
[Abstract]
[Full text]
[PDF]
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
- Donna E. Reece, Vaishali Sanchorawala, Ute Hegenbart, Giampaolo Merlini, Giovanni Palladini, Jean-Paul Fermand, Robert A. Vescio, Xiangyang Liu, Yusri A. Elsayed, Andrew Cakana, Raymond L. Comenzo, and for the VELCADE CAN2007 Study Group
Blood 2009; 114: 1489-1497.
[Abstract]
[Full text]
[PDF]
Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM
- Roberto Alonso, Mónica López-Guerra, Ramanda Upshaw, Shanta Bantia, Caroline Smal, Françoise Bontemps, Chantal Manz, Thomas Mehrling, Neus Villamor, Elias Campo, Emili Montserrat, and Dolors Colomer
Blood 2009; 114: 1563-1575.
[Abstract]
[Full text]
[PDF]
Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198–fibroblast growth factor receptor-1 chimeric tyrosine kinase
- Mingqiang Ren, Xiurong Li, and John K. Cowell
Blood 2009; 114: 1576-1584.
[Abstract]
[Full text]
[PDF]
The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways
- Megan S. Lim, Mary L. Carlson, David K. Crockett, G. Chris Fillmore, David R. Abbott, Olaotan F. Elenitoba-Johnson, Sheryl R. Tripp, George Z. Rassidakis, L. Jeffrey Medeiros, Philippe Szankasi, and Kojo S. J. Elenitoba-Johnson
Blood 2009; 114: 1585-1595.
[Abstract]
[Full text]
[PDF]
Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols
- Antje Hoering, John Crowley, John D Shaughnessy, Jr, Klaus Hollmig, Yazan Alsayed, Jackie Szymonifka, Sarah Waheed, Bijay Nair, Frits van Rhee, Elias Anaissie, and Bart Barlogie
Blood 2009; 114: 1299-1305.
[Abstract]
[Full text]
[PDF]
High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors
- Alessandro Re, Mariagrazia Michieli, Salvatore Casari, Bernardino Allione, Chiara Cattaneo, Maurizio Rupolo, Michele Spina, Rosa Manuele, Emanuela Vaccher, Mario Mazzucato, Luciano Abbruzzese, Pierino Ferremi, Giampiero Carosi, Umberto Tirelli, and Giuseppe Rossi
Blood 2009; 114: 1306-1313.
[Abstract]
[Full text]
[PDF]
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols
- Martin Stanulla, Elke Schaeffeler, Anja Möricke, Sally A. Coulthard, Gunnar Cario, André Schrauder, Peter Kaatsch, Michael Dördelmann, Karl Welte, Martin Zimmermann, Alfred Reiter, Michel Eichelbaum, Hansjörg Riehm, Martin Schrappe, and Matthias Schwab
Blood 2009; 114: 1314-1318.
[Abstract]
[Full text]
[PDF]
|
|
